Aravive Reports Positive Data Supporting Relationship Between AVB-500 Levels, Anti-Tumor Activity and Progression Free Survival in Women with Ovarian Cancer


You May Also Like

Cytori Announces Japan Class III Medical Device Approval for Cell Therapy Product

Expands medical device production capabilitiesSAN DIEGO and TOKYO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- ...

Radius Health to Present at the 36th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 05, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), today announced ...